UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linking science and policy to support the implementation of the Minamata Convention on Mercury

Ambio, 2018-03, Vol.47 (2), p.198-215

2018

Volltextzugriff (PDF)

Seed germination and vigor

Annual review of plant biology, 2012-01, Vol.63 (1), p.507-533

2012

Volltextzugriff (PDF)

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient

Haematologica (Roma), 2021-05, Vol.106 (8), p.2287-2290

2021

Volltextzugriff (PDF)

Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges

Journal of the American Society of Nephrology, 2022-03, Vol.33 (3), p.628-637

2022

Volltextzugriff (PDF)

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.554-557

2024

Volltextzugriff (PDF)

Emicizumab and asparaginase, A first experience to share

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-03, Vol.30 (2), p.561-563

2024

Volltextzugriff (PDF)

Emicizumab does not interfere with the activated clotting time

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.362-366

2022

Volltextzugriff (PDF)

Molecular and Cellular Interactions of Scavenger Receptor SR-F1 With Complement C1q Provide Insights Into Its Role in the Clearance of Apoptotic Cells

Frontiers in immunology, 2020-03, Vol.11, p.544-544

2020

Volltextzugriff (PDF)

Multimodal prehabilitation for major surgery in elderly patients to lower complications: protocol of a randomised, prospective, multicentre, multidisciplinary trial (PREHABIL Trial)

BMJ open, 2023-01, Vol.13 (1), p.e070253-e070253

2023

Volltextzugriff (PDF)

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-07, Vol.27 (4), p.e581-e584

2021

Volltextzugriff (PDF)

Emicizumab does not interfere with the activated clotting time

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-01, Vol.28 (2), p.362-366

2022

Volltextzugriff (PDF)

Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France

BMC health services research, 2018-01, Vol.18 (1), p.3-3, Article 3

2018

Volltextzugriff (PDF)

Metabolic adaptation in transplastomic plants massively accumulating recombinant proteins

PloS one, 2011-09, Vol.6 (9), p.e25289-e25289

2011

Volltextzugriff (PDF)

Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery

Diabetes care, 2019-07, Vol.42 (7), p.1344-1347

2019

Volltextzugriff (PDF)

Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1661-1664

2023

Volltextzugriff (PDF)

Scavenger receptors expressed by endothelial cells SREC-I/SR-F1 and SREC-II both interact with C1q and calreticulin

Molecular immunology, 2018-10, Vol.102, p.220-220

2018

Volltextzugriff (PDF)

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland

Clinical microbiology and infection, 2014-07, Vol.20 (7), p.698-705

2014

Volltextzugriff (PDF)

Copper Direct-Bonding Characterization and Its Interests for 3D Integration

Journal of the Electrochemical Society, 2009, Vol.156 (10), p.H772

2009

Volltextzugriff (PDF)

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

British journal of cancer, 2017-12, Vol.117 (12), p.1787-1797

2017

Volltextzugriff (PDF)

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

The Journal of infection, 2024-03, Vol.88 (3), p.106120-106120, Article 106120

2024

Volltextzugriff (PDF)

Methicillin-resistant Staphylococcus aureus : 15 years of molecular epidemiology in Western Switzerland

Revue médicale suisse, 2022-04, Vol.18 (777), p.724

2022

Volltextzugriff (PDF)

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

The Journal of infection, 2024-03, Vol.88 (3)

2024

Volltextzugriff (PDF)

[i]Staphylococcus aureus[/i] résistant à la méticilline : 15 ans de surveillance moléculaire en Suisse romande

Revue médicale suisse, 2022, Vol.18 (777), p.724-728

2022

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(18)
Life Sciences
(17)
Human Health And Pathology
(8)
Aged
(7)
Female
(7)
Hematology
(7)
Adult
(6)
Male
(6)
Middle Aged
(6)
Infectious Diseases
(5)
Prospective Studies
(4)
Retrospective Studies
(4)
Young Adult
(4)
Adolescent
(3)
Aged, 80 And Over
(3)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(3)
Candida
(3)
Factor Viii
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linking science and policy to support the implementation of the Minamata Convention on Mercury

Global mercury concentrations in biota: their use as a basis for a global biomonitoring framework

Seed germination and vigor

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient

Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Emicizumab and asparaginase, A first experience to share

Emicizumab does not interfere with the activated clotting time

Molecular and Cellular Interactions of Scavenger Receptor SR-F1 With Complement C1q Provide Insights Into Its Role in the Clearance of Apoptotic Cells

Multimodal prehabilitation for major surgery in elderly patients to lower complications: protocol of a randomised, prospective, multicentre, multidisciplinary trial (PREHABIL Trial)

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group

Emicizumab does not interfere with the activated clotting time

Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France

Metabolic adaptation in transplastomic plants massively accumulating recombinant proteins

Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery

Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab

Scavenger receptors expressed by endothelial cells SREC-I/SR-F1 and SREC-II both interact with C1q and calreticulin

Copper Direct-Bonding Characterization and Its Interests for 3D Integration

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Methicillin-resistant Staphylococcus aureus : 15 years of molecular epidemiology in Western Switzerland

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

[i]Staphylococcus aureus[/i] résistant à la méticilline : 15 ans de surveillance moléculaire en Suisse romande

Suchergebnisse filtern